Stock Scorecard
Stock Summary for Alcon Inc (ALC) - $78.77 as of 4/26/2024 8:52:19 PM EST
Total Score
15 out of 29
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for ALC
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ALC
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ALC
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 |
Bonus Criteria for ALC
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Latest News for for ALC
Financial Details for ALC
Company Overview |
|
|---|---|
| Ticker | ALC |
| Company Name | Alcon Inc |
| Country | USA |
| Description | Alcon, Inc., an eye care company, researches, develops, manufactures, distributes and sells eye care products for eye care professionals and their patients around the world. The company is headquartered in Geneva, Switzerland. |
| Sector Name | LIFE SCIENCES |
| Industry Name | OPHTHALMIC GOODS |
| Most Recent Quarter | 12/31/2023 |
| Next Earnings Date | 5/14/2024 |
Stock Price History |
|
| Last Day Price | 78.77 |
| Last Day Price Updated | 4/26/2024 8:52:19 PM EST |
| Last Day Volume | 1,115,931 |
| Average Daily Volume | 869,398 |
| 52-Week High | 88.23 |
| 52-Week Low | 69.44 |
| Last Price to 52 Week Low | 13.44% |
Valuation Measures |
|
| Trailing PE | 40.22 |
| Industry PE | 70.40 |
| Sector PE | 56.64 |
| 5-Year Average PE | 32.49 |
| Free Cash Flow Ratio | 35.48 |
| Industry Free Cash Flow Ratio | 59.39 |
| Sector Free Cash Flow Ratio | 30.65 |
| Current Ratio Most Recent Quarter | 2.28 |
| Total Cash Per Share | 2.22 |
| Book Value Per Share Most Recent Quarter | 41.81 |
| Price to Book Ratio | 1.94 |
| Industry Price to Book Ratio | 3.55 |
| Sector Price to Book Ratio | 22.15 |
| Price to Sales Ratio Twelve Trailing Months | 4.25 |
| Industry Price to Sales Ratio Twelve Trailing Months | 5.62 |
| Sector Price to Sales Ratio Twelve Trailing Months | 5.17 |
Share Statistics |
|
| Total Shares Outstanding | 493,244,000 |
| Market Capitalization | 38,852,829,880 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 5/14/2024 |
| Last Dividend Amount | 0.24 |
| Current Dividend Amount | 0.24 |
| Dividend Aristocrat? | False |
| Trailing Annual Dividend Rate | 0.69 |
| Trailing Annual Dividend Yield | 0.88% |
| Forward Annual Dividend Rate | 1.00 |
| Forward Annual Dividend Yield | 1.27% |
| 5-Year Dividend Payments Count | 5 |
| 3-Year Average Dividend Yield | 0.23% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 5.00% |
| 3-Year Dividend Growth Rate Percentage | 44.91% |
| 5-Year Dividend Growth Rate Percentage | 44.91% |
| All-Time Dividend Growth Rate Percentage | 44.91% |
| Dividend Payout Ratio | 35.20% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 78.30% |
| Annual Earnings Growth | 190.75% |
| Reported EPS 12 Trailing Months | 1.96 |
| Reported EPS Past Year | 0.00 |
| Reported EPS Prior Year | 2.74 |
| Net Income Twelve Trailing Months | 974,000,000 |
| Net Income Past Year | 974,000,000 |
| Net Income Prior Year | 335,000,000 |
| Quarterly Revenue Growth YOY | 8.30% |
| 5-Year Revenue Growth | 7.13% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 1,093,629,539 |
| Total Cash Past Year | 1,093,629,539 |
| Total Cash Prior Year | 980,000,000 |
| Net Cash Position Most Recent Quarter | -3,500,370,461 |
| Net Cash Position Past Year | -3,500,370,461 |
| Long Term Debt Past Year | 4,594,000,000 |
| Long Term Debt Prior Year | 4,541,000,000 |
| Total Debt Most Recent Quarter | 4,594,000,000 |
| Equity to Debt Ratio Past Year | 0.82 |
| Equity to Debt Ratio Most Recent Quarter | 0.82 |
| Total Stockholder Equity Past Year | 20,617,016,115 |
| Total Stockholder Equity Prior Year | 19,677,000,000 |
| Total Stockholder Equity Most Recent Quarter | 20,617,016,115 |
Options |
|
| Put/Call Ratio | 8.15 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.96 |
| MACD Signal | -0.65 |
| 20-Day Bollinger Lower Band | 72.41 |
| 20-Day Bollinger Middle Band | 80.00 |
| 20-Day Bollinger Upper Band | 87.59 |
| Beta | 0.67 |
| RSI | 35.64 |
| 50-Day SMA | 79.13 |
| 200-Day SMA | 72.53 |
System |
|
| Modified | 4/26/2024 5:29:47 PM EST |